Back to MORGAN STANLEY MORGAN STANLEY

CRVSCRVS
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CORVUS PHARMACEUTICALS INC

MORGAN STANLEY holds 1.3M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $20.1M as of 2026-Q2. The position was decreased (-46.2% shares). CRVS represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$20.1M

Current Shares

1.3M

Total Value Change

+$18M

Total Shares Change

+951,474

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-46.2%
$20.1M0.0%$14.94
0
2026-Q1
Decreased
2.5M
-30.0%
$36.6M0.0%$17.53
0
2025-Q4
Increased
3.6M
+478.1%
$27.5M0.0%$7.49
46
2025-Q3
Decreased
617,224
-31.0%
$4.5M0.0%$7.28
0
2025-Q2
Increased
894,405
+32.8%
$3.6M0.0%$3.89
34
2025-Q1
Increased
673,524
+69.5%
$2.1M0.0%$3.38
39
2024-Q4
Increased
397,364
+1.0%
$2.1M0.0%$5.25
26
2024-Q3
Increased
393,262
+5.9%
$2.1M0.0%$5.15
28

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used